| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report | Circulation | 2002 | 12,581 |
| 2 | Harmonizing the Metabolic Syndrome | Circulation | 2009 | 11,902 |
| 3 | Diagnosis and Management of the Metabolic Syndrome | Circulation | 2005 | 9,969 |
| 4 | Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association | Circulation | 2017 | 7,294 |
| 5 | Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association | Circulation | 2019 | 6,572 |
| 6 | Heart Disease and Stroke Statistics—2015 Update | Circulation | 2015 | 6,088 |
| 7 | Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association | Circulation | 2020 | 5,971 |
| 8 | General Cardiovascular Risk Profile for Use in Primary Care | Circulation | 2008 | 5,847 |
| 9 | Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines | Circulation | 2004 | 5,645 |
| 10 | Heart Disease and Stroke Statistics—2016 Update | Circulation | 2016 | 5,588 |
| 11 | Markers of Inflammation and Cardiovascular Disease | Circulation | 2003 | 5,481 |
| 12 | Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association | Circulation | 2018 | 5,461 |
| 13 | Particulate Matter Air Pollution and Cardiovascular Disease | Circulation | 2010 | 5,175 |
| 14 | Clinical End Points in Coronary Stent Trials | Circulation | 2007 | 5,055 |
| 15 | 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults | Circulation | 2014 | 4,948 |
| 16 | Definition of Metabolic Syndrome | Circulation | 2004 | 4,680 |
| 17 | Heart Disease and Stroke Statistics—2014 Update | Circulation | 2014 | 4,579 |
| 18 | Heart Disease and Stroke Statistics—2011 Update | Circulation | 2011 | 4,437 |
| 19 | Heart Disease and Stroke Statistics—2013 Update | Circulation | 2013 | 4,431 |
| 20 | Heart Disease and Stroke Statistics—2012 Update | Circulation | 2012 | 4,134 |
| 21 | Heart Disease and Stroke Statistics—2010 Update | Circulation | 2010 | 4,105 |
| 22 | Physical Activity and Public Health | Circulation | 2007 | 3,843 |
| 23 | Heart Disease and Stroke Statistics—2021 Update | Circulation | 2021 | 3,820 |
| 24 | Worldwide Epidemiology of Atrial Fibrillation | Circulation | 2014 | 3,712 |
| 25 | Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction | Circulation | 2010 | 3,710 |
| 26 | 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation | Circulation | 2014 | 3,560 |
| 27 | Standardized Bleeding Definitions for Cardiovascular Clinical Trials | Circulation | 2011 | 3,529 |
| 28 | ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary | Circulation | 2004 | 3,325 |
| 29 | Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association | Circulation | 2023 | 3,256 |
| 30 | ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease | Circulation | 2006 | 3,210 |
| 31 | Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association | Circulation | 2022 | 3,119 |
| 32 | Kidney Disease as a Risk Factor for Development of Cardiovascular Disease | Circulation | 2003 | 3,117 |
| 33 | Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease | Circulation | 2002 | 3,081 |
| 34 | Contemporary Definitions and Classification of the Cardiomyopathies | Circulation | 2006 | 3,001 |
| 35 | Atrial Fibrillation Begets Atrial Fibrillation | Circulation | 1995 | 2,966 |
| 36 | ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic) | Circulation | 2006 | 2,959 |
| 37 | A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association | Circulation | 1975 | 2,954 |
| 38 | 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk | Circulation | 2014 | 2,948 |
| 39 | Heart Disease and Stroke Statistics—2008 Update | Circulation | 2008 | 2,886 |
| 40 | Coronary Plaque Disruption | Circulation | 1995 | 2,885 |
| 41 | 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary | Circulation | 2013 | 2,841 |
| 42 | Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis | Circulation | 2002 | 2,824 |
| 43 | Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies | Circulation | 1996 | 2,816 |
| 44 | Third Universal Definition of Myocardial Infarction | Circulation | 2012 | 2,795 |
| 45 | Universal Definition of Myocardial Infarction | Circulation | 2007 | 2,794 |
| 46 | Forecasting the Future of Cardiovascular Disease in the United States | Circulation | 2011 | 2,747 |
| 47 | 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction | Circulation | 2013 | 2,709 |
| 48 | Heart Disease and Stroke Statistics—2007 Update | Circulation | 2007 | 2,704 |
| 49 | Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness | Circulation | 2007 | 2,654 |
| 50 | 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Circulation | 2019 | 2,589 |
